BayOConnect 2026 on 30 June - 1 July 2026 in Munich highlights what truly drives growth in biotechnology: Europe as a competitive innovation hub, capital turning innovation into scale, and breakthrough technologies shaping biotech and beyond. Following our initial announcement, BayOConnect further expands its agenda with additional sessions, speakers and strategic perspectives shaping Europe’s biotech landscape.
Registration is now open. Secure your ticket today!
Here’s an updated glimpse at newly added program highlights:
Driving Biotech in Europe
Focusing on Europe’s strategic positioning, this part of the program introduces new perspectives on technological sovereignty and resilience. Tobias Gotthardt (StMWi) highlights the role of key technologies, while Carsten Rudolph (Ethris GmbH) contributes to the discussion on pandemic and technological resilience in Europe.
Unlocking Europe’s Capital for Biotech Innovation
Building on the importance of financing, this session brings together Rainer Becker (DG SANTE), Karl Nägler (Sofinnova), Dmitrij Hristodorov (Forbion) and Michael Bauer (Novo Holdings) to discuss how capital can be mobilized to scale biotech innovation across Europe.
Spotlight Bavaria: Driving Success for Biotech Startups
New insights into Bavaria’s startup ecosystem will be shared by Carsten Rudolph and Barbara Dombay (BayStartUP), Nathalie Weitemeyer (Bayern Kapital), Achim Plum (HTGF), Maria Sievert (TUM Venture Labs) and Petra Burgstaller (BioM), highlighting success factors for early-stage companies.
Innovation cleared for Market: How do we ensure regulatory and clinical success for game-changers in biotech?
Addressing the path from innovation to approval, this session features Ulrich H. Granzer (Granzer), Thomas Sudhop (BfArM) and Martin Hrabě de Angelis (Helmholtz Munich), focusing on regulatory and clinical success factors for breakthrough therapies.
Excellence Clusters and Startups Shaping Translation in Bavaria
This session showcases emerging ventures and scientific excellence, featuring Olivia Merkel (RNhale, LMU), Hendrik Dietz (CPTx, TUM) and Ali Ertürk (Deep Piction, Helmholtz), illustrating how research translates into impactful startups.
Further Program Additions
Additional highlights include sessions on brain-computer interfaces with Simon Jacob (TUM), investment perspectives moderated by Timo Pache (Capital) and featuring Alissa Zeller (BASF), Elena Lovo (J.P. Morgan) and Olivier Litzka (Andera Partners), as well as the BayOConnect Innovation Award and dedicated startup pitch sessions.
BayOConnect 2026: A Platform For Europe’s Future
With these additions, BayOConnect 2026 further strengthens its role as a platform connecting innovation, capital and collaboration across Europe’s biotech ecosystem.
Check out the full program here.
Registration is now open. Secure your ticket today!